FLT3 Mutations: Significance in Paediatric AML
International Blood Research & Reviews · pp. 1–7 · Published 13 Aug 2018
10.9734/IBRR/2018/42466Abstract
Patients with acute myeloid leukaemia (AML) who have FMS-like tyrosine kinase 3 (FLT3) mutations are a concern for haematologists. Many studies indicate that these patients have poor prognosis. Due to the dearth of research in this area, the role of allogeneic transplantation as a therapy is still controversial. But the available limited data suggest that transplantation in first remission is possibly the first choice. As FTL3 mutations in AML result in poor patient outcomes, different FLT3 inhibitors are used as specific targeted therapy.
Cited by 0
No indexed citations yet.
Related research
- Do Diets Affect Haematological Parameters of Poultry? — shares topic coverage
- Haematological Consequences of Systemic Inflammation: A Critical Narrative Review of Pathophysiology, Clinical Manifestations, Biomarkers and Therapeutic Implications — shares topic coverage
- Effect of Chloroform Leaf Extracts of Portulaca oleracea Linn. (Purslane) on Haematological Parameters in Albino Wistar Rats — shares topic coverage
- Haematopoietic and Inflammatory Cytokines in Type 2 Diabetes Mellitus Patients in Enugu Metropolis, South East Nigeria — shares topic coverage
- Consumption of Tiger Nut (Cyperus esculentus L.) Improves Haematopoiesis in Wistar Rats — shares topic coverage
Article metrics
Real usage data collected on this platform.
25
Page views
0
PDF downloads
4
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.